Point-in-time · survivorship-free · back to 1993

Restatement Radar

The numbers companies quietly changed. Every event is a before/after diff, traced to the exact SEC filing — the kind of thing only a point-in-time archive can surface.

All Major Notable Minor

YSXTYSX Tech Co., Ltd
10th largest revision in YSXT's history
Liabilities, Current
FY 2025
Notable restatement
As reported
$12.1M
Restated
$11.4M
-6.3%
FTRKFast Track Group
6th largest revision in FTRK's history
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Including Disposal Group and Discontinued Operations
FY 2025
Notable restatement
As reported
$198.9K
Restated
$212.4K
6.8%
FTRKFast Track Group
4th largest revision in FTRK's history
Adjustments to Additional Paid in Capital, Other
FY 2024
Notable restatement
As reported
1.1MSGD
Restated
1MSGD
-7.1%
FTRKFast Track Group
5th largest revision in FTRK's history
Contract with Customer, Liability, Current
FY 2025
Notable restatement
As reported
$403.7K
Restated
$431.1K
6.8%
MFBIMonroe Federal Bancorp, Inc.
5th largest revision in MFBI's history
Noninterest Income
FY 2025
Notable restatement
As reported
$354K
Restated
$376.3K
6.3%
MFBIMonroe Federal Bancorp, Inc.
6th largest revision in MFBI's history
Common Stock, Shares, Issued
FY 2025
Notable restatement
As reported
526.4Kshares
Restated
541.4Kshares
2.8%
SAILSailPoint, Inc.
3rd largest revision in SAIL's history
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents
Q1 2025
Notable restatement
As reported
$121.3M
Restated
$124.4M
2.6%
YDESYD Bio Ltd
4th largest revision in YDES's history
Adjustments to Additional Paid in Capital, Stock Issued, Issuance Costs
FY 2024
Notable restatement
As reported
$8.5M
Restated
$8M
-5.7%
YDESYD Bio Ltd
5th largest revision in YDES's history
Effective Income Tax Rate Reconciliation, Change in Deferred Tax Assets Valuation Allowance, Amount
FY 2025
Notable restatement
As reported
$552.8K
Restated
$583.9K
5.6%
RMSGReal Messenger Corp
7th largest revision in RMSG's history
Net Income (Loss) Available to Common Stockholders, Basic
FY 2025
Notable restatement
As reported
-$3.3M
Restated
-$3.4M
-2.7%
YDESYD Bio Ltd
6th largest revision in YDES's history
Effective Income Tax Rate Reconciliation, Change in Deferred Tax Assets Valuation Allowance, Amount
FY 2024
Notable restatement
As reported
$168.9K
Restated
$172.7K
2.3%
HSPTHorizon Space Acquisition II Corp.
6th largest revision in HSPT's history
Earnings Per Share, Diluted
Q1 2025
Notable restatement
As reported
0.1USD/shares
Restated
0.1USD/shares
3.9%
AESPAeon Acquisition I Corp.
2nd largest revision in AESP's history
Additional Paid in Capital
2025
Notable restatement
As reported
$23.8K
Restated
$24.4K
2.6%
RCTRedCloud Holdings plc
6th largest revision in RCT's history
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents
FY 2023
Notable restatement
As reported
$554.7K
Restated
$587.1K
5.8%
ATHRAether Holdings, Inc.
3rd largest revision in ATHR's history
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents
Q2 2025
Notable restatement
As reported
$179.2K
Restated
$193.3K
7.8%
PLMKPlum Acquisition Corp, IV
2nd largest revision in PLMK's history
Increase (Decrease) in Prepaid Expense and Other Assets
Q1 2025
Notable restatement
As reported
$65.1K
Restated
$67.3K
3.3%
DTCKFDAVIS COMMODITIES Ltd
6th largest revision in DTCKF's history
Interest Expense, Debt
FY 2023
Notable restatement
As reported
$110K
Restated
$103K
-6.4%
DTCKFDAVIS COMMODITIES Ltd
10th largest revision in DTCKF's history
Common Stock, Shares, Outstanding
FY 2022
Notable restatement
As reported
24.5Mshares
Restated
23.3Mshares
-5.1%
NXNTNexscient, Inc.
5th largest revision in NXNT's history
Operating Expenses
Q3 2025
Notable restatement
As reported
$114.6K
Restated
$108.1K
-5.7%
NXNTNexscient, Inc.
6th largest revision in NXNT's history
General and Administrative Expense
Q3 2025
Notable restatement
As reported
$114.6K
Restated
$108.1K
-5.7%
LUDLuda Technology Group Ltd
6th largest revision in LUD's history
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents
FY 2022
Notable restatement
As reported
$4.1M
Restated
$4.3M
3.9%
LUDLuda Technology Group Ltd
5th largest revision in LUD's history
Contract with Customer, Liability, Revenue Recognized
FY 2023
Notable restatement
As reported
$225.5K
Restated
$214.6K
-4.8%
TMDETMD Energy Ltd
8th largest revision in TMDE's history
Comprehensive Income (Loss), Net of Tax, Attributable to Parent
FY 2024
Notable restatement
As reported
$2.3M
Restated
$2.2M
-7.2%
TMDETMD Energy Ltd
9th largest revision in TMDE's history
Operating Lease, Right-of-Use Asset, Amortization Expense
FY 2023
Notable restatement
As reported
$21.7K
Restated
$21.1K
-2.8%
NMAXNewsmax Inc.
6th largest revision in NMAX's history
Lease, Cost
Q1 2025
Notable restatement
As reported
$1.2M
Restated
$1.2M
-3.1%
ATIIArchimedes Tech SPAC Partners II Co.
2nd largest revision in ATII's history
General and Administrative Expense
Q1 2025
Notable restatement
As reported
$146.7K
Restated
$157.5K
7.4%
ATIIArchimedes Tech SPAC Partners II Co.
Financials
Operating Income (Loss)
Q1 2025
Notable restatement
As reported
-$146.7K
Restated
-$157.5K
-7.4%
AIIAmerican Integrity Insurance Group, Inc.
5th largest revision in AII's history
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents
Q1 2024
Notable restatement
As reported
$173.2M
Restated
$179.3M
3.5%
INBXInhibrx Biosciences, Inc.
7th largest revision in INBX's history
Increase (Decrease) in Accounts Receivable
Q1 2025
Notable restatement
As reported
-$183K
Restated
-$200K
-9.3%
USGOU.S. GoldMining Inc.
5th largest revision in USGO's history
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Including Disposal Group and Discontinued Operations
Q1 2025
Notable restatement
As reported
$3M
Restated
$3M
2.9%
USGOU.S. GoldMining Inc.
6th largest revision in USGO's history
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Including Disposal Group and Discontinued Operations
Q1 2024
Notable restatement
As reported
$3.9M
Restated
$4M
2.2%
NAKANakamoto Inc.
10th largest revision in NAKA's history
Share-based Payment Arrangement, Noncash Expense
Q1 2025
Notable restatement
As reported
$8.3K
Restated
$9K
8.3%
PHXE-PPhoenix Energy One, LLC
5th largest revision in PHXE-P's history
Net Cash Provided by (Used in) Financing Activities
Q1 2025
Notable restatement
As reported
$81M
Restated
$78.8M
-2.6%
ACRVAcrivon Therapeutics, Inc.
2nd largest revision in ACRV's history
Lease, Cost
Q1 2025
Notable restatement
As reported
$417K
Restated
$400K
-4.1%
INRINFINITY NATURAL RESOURCES, INC.
Energy
Operating Lease, Expense
Q1 2025
Notable restatement
As reported
$7.4M
Restated
$6.8M
-8.9%
GUTSFRACTYL HEALTH, INC.
8th largest revision in GUTS's history
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents
Q1 2024
Notable restatement
As reported
$67.5M
Restated
$71.7M
6.3%
IVHIInvech Holdings, Inc.
Industrials
General and Administrative Expense
Q1 2025
Notable restatement
As reported
$31.4K
Restated
$28.8K
-8.2%
SIONSionna Therapeutics, Inc.
5th largest revision in SION's history
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents
Q1 2024
Notable restatement
As reported
$37.8M
Restated
$38.8M
2.5%
PLUTPlutus Financial Group Ltd
7th largest revision in PLUT's history
Deferred Tax Assets, Net of Valuation Allowance
FY 2021
Notable restatement
As reported
329KHKD
Restated
314KHKD
-4.6%
PLUTPlutus Financial Group Ltd
6th largest revision in PLUT's history
Deferred Tax Assets, Net of Valuation Allowance
FY 2021
Notable restatement
As reported
$42K
Restated
$39K
-7.1%